Press Releases
EndoGastric Solutions, Inc.® Announces TIF® Procedure Included in New American Gastroenterology Association (AGA) Clinical Practice Update and American College of Gastroenterology (ACG) Guideline
— Leading Gastroenterology Experts Recommend Transoral Incisionless Fundoplication (TIF) for Select Patients with Gastroesophageal Reflux Disease (GERD) — REDMOND, Wa.--(BUSINESS WIRE)--EndoGastric Solutions, Inc.® today announced that the American Gastroenterology...
GERDHelp™ Mobile App to Assist GERD Patients in Navigating Their Journey With Individualized Education and Support, Provided by EndoGastric Solutions®
- Developed in partnership with DoctorPlan®, the app utilizes data to connect patients with expert clinicians as they jointly develop individualized plans for GERD treatment - REDMOND, Wash – June 23, 2021 – EndoGastric Solutions® today released the GERDHelp™...
New Publication on TIF 2.0 in Therapeutic Advances in Gastroenterology Provides a Roadmap as Surgeons and Gastroenterologists Partner to Use the Procedure to Achieve Optimal Outcomes for Patients with Gastroesophageal Reflux Disease (GERD)
Continued evolution of EndoGastric Solutions’ EsophyX technology and concomitant use of TIF 2.0 with hiatal hernia repair brings long-term GERD relief to a broader spectrum of patients REDMOND, Wash – June 17, 2020 – EndoGastric Solutions® today announced the...
EndoGastric Solutions Announces New Data Confirming the Efficacy of Concomitant Hiatal Hernia Repair and TIF 2.0 Procedure in Providing Symptom Control for GERD Patients
A 99-patient study confirms that a laparo-endoluminal approach reduces proton pump inhibitor medication use and significantly improves quality-of-life scores REDMOND, Wash – EndoGastric Solutions® today announced the publication of new clinical data confirming that...
EndoGastric Solutions’ TIF 2.0 Procedure Highlighted in Multiple Sessions at DDW 2019
EGS to host DDW Product Theater session showcasing the evolution of TIF 2.0 procedure along with updates on concomitant hiatal hernia repair REDMOND, Wash. – EndoGastric Solutions® today announced that new data on the Transoral Incisionless Fundoplication (TIF® 2.0)...
EndoGastric Solutions® Announces New Data Demonstrating pH Control Following TIF 2.0 and Hiatal Hernia Repair Procedures in GERD Patients
- 95% of patients achieved normal pH exposure levels following concomitant HHR and TIF 2.0 procedures - - GERD-related quality of life and reflux symptom scores also improved significantly - REDMOND, Wash. – EndoGastric Solutions today announced the publication of new...
EndoGastric Solutions Announces Data Presented at ACG 2018 Provide Additional Validation of the Safety and Clinical Efficacy of TIF 2.0 Procedure for the Treatment of GERD
Amit Sohagia, MD received ACG’s Outstanding Poster Presenter Award for TIF 2.0 procedure poster REDMOND, Wash. – EndoGastric®Solutions today announced the presentation of three posters at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting...
EndoGastric Solutions Announces New Data at Digestive Disease Week 2018 Supporting the Durability and Efficacy of TIF 2.0 Procedure for GERD Patients
TIF 2.0 procedure provides improved quality of life and elimination of daily PPI use for up to 10 years in patients with symptomatic GERD; TIF 2.0 procedure combined with laparoscopic hiatal hernia repair is a safe and effective option for patients with severe GERD...
EndoGastric Solutions Announces Publication of Meta-Analysis Further Validating TIF 2.0 procedure as an Appropriate Treatment Option for Refractory GERD Patients
TIF Procedure offers excellent short and long-term relief for the majority of chronic GERD patients. REDMOND, Wash – EndoGastric® Solutions today announced the publication of a meta-analysis supporting the clinical utility of Transoral Incisionless Fundoplication...